Chronic Myeloproliferative Disorders Active Not Recruiting Phase 0 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00424242Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesTreatment